Nanophytomedicine is a field that involves the application of nanomedicine-based systems to phytotherapy and phytopharmacology. This book assesses the clinical successes and failures of nanophytomedicine and also highlights emerging concepts in this field. The content is divided into three sections, the first of which describes core issues in the pharmaceuticals industry in connection with the successes, failures and prospects of nanophytomedicine. The second section highlights recent advances in phytomedicine formulation development based on nanotechnology approaches, while also discussing a variety of nanocarrier systems for the successful delivery of phytomedicines. Focusing on the clinical perspective, the third section addresses the current clinical status of nanophytomedicine as a single drug therapy or combinatorial drug therapy, pharmacovigilance, pharmacokinetics, drug interactions and toxicological profiles, while also providing concluding remarks on recent experimental findings, and considering ethical issues & regulatory challenges in nanophytomedicine.

Given its scope, the book offers a valuable guide for early career researchers, young scientists, master level students, academics and industrial scientists working in various healthcare fields, e.g. the pharmaceutical and biological sciences, life sciences, biotechnology, biomedical engineering, and nanobiotechnology.

Autorentext

Dr. Sarwar Beg is currently serving as an Assistant Professor at the Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. Prior to joining Jamia Hamdard, Dr Beg was a Research Scientist at Jubilant Generics Limited, Noida, India. He has over a decade of research experience in the field of pharmaceutics, especially in the systematic development and characterization of diverse drug delivery systems employing Quality by Design paradigms like Design of Experiments and Multivariate Statistical Techniques. To date he has authored over 160 publications in various peer-reviewed journals, 45 book chapters and 12 books. Dr Beg has also participated in and presented his research work at several conferences in India, China, Bangladesh, Saudi Arabia, the UAE, USA and Canada, and has several best paper awards and young scientist awards to his credit.

Dr. Md Abul Barkat is currently serving as an Assistant Professor at the Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Kingdom of Saudi Arabia. He holds a Master's degree in Pharmaceutical Sciences from Jamia Hamdard University, New Delhi, India, and a PhD in Pharmaceutical Sciences (Pharmaceutics) from the Integral University Lucknow, India. With more than 10 years of teaching and research experience in the field of Pharmaceutical Science, his research interests include the development and optimization of herbal/synthetic based nanostructured delivery systems, controlled release drug delivery systems, bio-enhanced drug delivery systems, nanomaterials and nanocomposites for a variety of conditions like burns, cancer etc. To date he has authored more than 30 research and review publications in various peer-reviewed journals, 6 book chapters and 7 books.

Dr. Farhan Jalees Ahmad is currently serving as a Professor at the Department of Pharmaceutics, School of Pharmaceutical Education and Research, and is a former Dean of Interdisciplinary Sciences at Jamia Hamdard, New Delhi, India. An internationally respected researcher in the area of Pharmaceutical Sciences with M.Pharma and PhD (Medicine) degrees from Jamia Hamdard, he continues to teach and leads a very productive research group, which has been extensively supported by national and international funding agencies. Prof Ahmad has 28 years of experience in research and education, with focus areas including the development, scale-up, technology transfer and launching of pharmaceutical products, both for domestic and international markets. He has published more than 300 research and review papers, 12 book chapters and 9 books.

Inhalt
S.No.Chapter TitlesSection-I: Nanophytomedicine: Current perspective1.Introduction to Nanophytomedicine: Current progress and challenges2.Nanophytomedicine Market: Global opportunity analysis and industry forecast3.Emergence of nanophytomedicine in healthcare settingSection-II: Nanophytomedicine: Drug delivery perspective4.Nanophytomedicine: an effective way for improving drug delivery and bioavailability of phytomedicines5.Lipid-based herbal nanotherapeutics in disease diagnosis & treatment6.Polymer-based herbal nanotherapeutics for disease diagnosis & treatment7.Potential of nanostructured drug delivery system for phytomedicine deliverySection-III: Nanophytomedicine: Clinical perspective8.Evidence-based review forecasting the successes and failures of Nanophytomedicine Clinical Trials9.Insights of nanophytomeidicines as a combinatorial therapy in disease diagnosis & treatment10.Pharmacokinetics, interaction, and toxicological profile of nanophytomedicine11.New dimensions in nanophytomedicine research & application12.Nanophytomedicine ethical issues, regulatory aspects and challenges